Skip to search formSkip to main contentSkip to account menu

DC 159a

Known as: DC-159a, DC159a 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Background Fluoroquinolones are a class of antibacterial agents used for leprosy treatment. Some new fluoroquinolones have been… 
Review
2012
2011
2011
ABSTRACT DC-159a is a new fluoroquinolone with more potent in vitro activity than available fluoroquinolones against both drug… 
2011
2011
ABSTRACT A G88C mutation in GyrA is one of the key alterations by which Mycobacterium tuberculosis mutants acquire DC-159a… 
2010
2010
ABSTRACT The in vitro activities of DC-159a against seven species of Mycobacterium were compared with moxifloxacin, gatifloxacin… 
2008
2008
OBJECTIVES DC-159a (a novel quinolone) and sitafloxacin (DU-6859a) are structurally related quinolones, bearing a 3… 
2008
2008
ABSTRACT The activity of DC-159a, a novel orally administered fluorinated quinolone, was evaluated by reference broth… 
2008
2008
ABSTRACT The in vitro susceptibilities of 151 unique clinical isolates of Mycoplasma pneumoniae, Mycoplasma hominis, Mycoplasma… 
Highly Cited
2007
Highly Cited
2007
ABSTRACT DC-159a is a new 8-methoxy fluoroquinolone that possesses a broad spectrum of antibacterial activity, with extended… 
2007
2007
ABSTRACT DC-159a yielded MICs of ≤1 μg/ml against 316 strains of both quinolone-susceptible and -resistant pneumococci…